Janssen Healthcare
Innovation’s Care4Today programme is set to take two of the highest honours at
the 2015 eyeforpharma Barcelona Awards as the shortlist was today announced.
Both their Orthopaedic
Solutions and Heart Health Solutions initiatives are shortlisted for the ‘Most
Valuable Patient’ and ‘Most Valuable HCP’ initiatives, respectively; a
testament to the success of the brand’s commitment to transforming healthcare
for the consumer.
The names of the shortlisted
projects selected from hundreds of initiatives from Europe, Middle East, Africa
and Asia/Pac, were released today and have been identified by the judging panel
as the
front-runners in customer innovation and value creation in the industry.
Favouring projects which could
demonstrate a real improvement in the lives of the consumer, judge Steve
Turley, Lundbeck, commented of the Heart Health Solutions programme: “this is
an excellent project based on deep and meaningful insight, making a real
difference for the company, HCPs, and patients”. The initiative is a
comprehensive cardiac rehabilitation programme which digitises health records allowing for improved referral
and recruitment of patients onto cardiac rehabilitation and providing engaging
and interactive exercise programmes for patients based on
real-time data.
A comprehensive list of finalists can be found online here: http://www.eyeforpharma.com/barcelona/awards-index.php
Winners will be announced at the 2nd
annual eyeforpharma Barcelona Awards on Tuesday 24th March at the
CCIB, Barcelona from 7.30pm, as part of the largest
gathering of pharma executives, eyeforpharma Barcelona. The evening will be attended by the top 200 VIPs from the pharma
industry.
For more information contact Awards Manager, Chloe Leighton on
chloe@eyeforpharma.com or visit
www.eyeforpharma.com/barcelona/awards